Vaxserve LLP - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
LLPIN AAF-9381 Incorporated 15 March 2016 ROC Delhi HQ New Delhi, Delhi, India
Active Limited Liability Partnership pharma
Revenue · FY 2023
₹11.24 Cr
▲ 13% YoY
Net profit · FY 2023
₹5.47 Lakh
Net margin 0.5%
EBITDA · FY 2023
₹54.7 Lakh
EBITDA margin 4.9%
Contribution obligation
₹1 Lakh
As per LLP agreement
Open charges
₹3 Cr
Secured borrowings
LLP age
10 yrs
Est. 2016
Designated partners
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Vaxserve LLP

Data last updated:

Vaxserve LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 2016 and has been in existence for over 10 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAF-9381.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Ruchir Gupta and Amit Kumar Garg.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at House No. 89 Second Floor Banarasi Dass Estate Timarpur Delhi – 110, 054, New Delhi, Delhi, India – 110054.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹11.24 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹5.47 Lakh (net margin 0.5%) and EBITDA of ₹54.7 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 38% over five years.

As per MCA filings, the LLP has open charges of ₹3 Cr on record. Court records list 3 cases involving the LLP, including 3 filed against it; 1 case is pending.

Company details

LLPIN AAF-9381
Incorporation Date 15 March 2016
Total Obligation of Contribution ₹1 Lakh
ROC Delhi
Company Status Active

Contact details

Vaxserve LLP's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    House No. 89 Second Floor Banarasi Dass Estate Timarpur Delhi – 110, 054, New Delhi, Delhi, India – 110054
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Vaxserve LLP, buy the company report.

Comprehensive company report
Vaxserve LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Vaxserve LLP

FY 2025 filings available

Vaxserve LLP reported revenue of ₹11.24 Cr (up 13% YoY) for FY 2023.

Revenue · FY 2023
₹11.24 Cr ▲ 13%
Net profit · FY 2023
₹5.47 Lakh margin 0.5%
EBITDA · FY 2023
₹54.7 Lakh margin 4.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 16%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 515%

Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 13% growth in the latest year. EBITDA rose 515% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹5.47 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin0.5%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Vaxserve LLP, buy the company report.

Designated partners of Vaxserve LLP

Vaxserve has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Ruchir GuptaDesignated Partner15 Mar 201610 Years 8 MonthsCurrent
Amit Kumar GargPartner15 Mar 201610 Years 8 MonthsCurrent
Vishal Kumar GargDesignated Partner15 Mar 201610 Years 8 MonthsCurrent

Charges & borrowings

Open charges
₹3 Cr
Satisfied charges
None
Breakdown by lending institutions
Icici Bank Limited₹3.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Sep 2022100609259Icici Bank Limited₹3 CrOpen

To see the full charge records of Vaxserve LLP, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vaxserve LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Vaxserve LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Vaxserve LLP has 3 designated partner changes on record since 2016: 3 appointments. The latest: Amit Kumar Garg was appointed as Partner on 15 Mar 2016.

AGM
Vaxserve Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Vaxserve Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Icici Bank Limited of Rs. 300.00 Lakh registered on 15 Sep 2022 with Charge ID 100609259 was modified on 20 Jul 2024.
Charges
A charge with Icici Bank Limited amounted to Rs. 300.00 Lakh with Charge ID 100609259 was registered on 15 Sep 2022.
Appointed
Amit Kumar Garg was appointed as Partner.
Appointed
Ruchir Gupta was appointed as Designated Partner.
Appointed
Vishal Kumar Garg was appointed as Designated Partner.
Incorporation
15 Mar 2016
Vaxserve Llp was registered on 15 Mar 2016 with Roc Delhi & aged 10 years 8 months as per MCA records.

Frequently asked questions

Vaxserve is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 2016 (10+ years old) and is registered under LLPIN AAF-9381.

Vaxserve has 3 current designated partners:

The latest financial statements of Vaxserve on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Vaxserve is AAF-9381. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Vaxserve has 3 court cases on record: 3 filed against it. 1 is pending.

Vaxserve was incorporated on 15 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.

Amit Kumar Garg was appointed as Partner on 15 Mar 2016. Ruchir Gupta was appointed as Designated Partner on 15 Mar 2016. Vishal Kumar Garg was appointed as Designated Partner on 15 Mar 2016.

The registered office of Vaxserve is at House No. 89 Second Floor Banarasi Dass Estate Timarpur Delhi – 110, 054, New Delhi, Delhi, India – 110054.

Vaxserve operates in the pharma industry, in the drug formulation and development segment.

Vaxserve has open charges of ₹3 Cr and no satisfied charges on record as per latest MCA filings.